Central nervous system screening in capillary malformation-arteriovenous malformation syndrome: An observational study - 16/09/22
Doi : 10.1016/j.jaad.2021.12.030
Olivia Boccara, MD a, ⁎ 
, Juliette Mazereeuw, MD, PhD b, Ludovic Martin, MD, PhD c, Didier Bessis, MD, PhD d, Thomas Hubiche, MD e, Christine Chiaverini, MD e, Anne Dompmartin, MD, PhD f, Stéphanie Mallet, MD g, Juliette Miquel, MD h, Hélène Aubert, MD i, Eve Puzenat, MD j, Claire Abasq, MD k, Laurence Gusdorf, MD l, Smail Hadj-Rabia, MD, PhD a, Annabel Maruani, MD, PhD m
, Juliette Mazereeuw, MD, PhD b, Ludovic Martin, MD, PhD c, Didier Bessis, MD, PhD d, Thomas Hubiche, MD e, Christine Chiaverini, MD e, Anne Dompmartin, MD, PhD f, Stéphanie Mallet, MD g, Juliette Miquel, MD h, Hélène Aubert, MD i, Eve Puzenat, MD j, Claire Abasq, MD k, Laurence Gusdorf, MD l, Smail Hadj-Rabia, MD, PhD a, Annabel Maruani, MD, PhD mGroupe de Recherche Clinique de Dermatologie Pédiatrique (GRDP,)
and theFilière Maladies rares Dermatologiques (FIMARAD)
a Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université Paris, Paris-centre, Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France
b Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases, Paul Sabatier University Toulouse, Larrey Hospital, Toulouse, France
c Department of Dermatology, CHU Angers, Angers, France
d Department of Dermatology, CHU Montpellier, Montpellier, France
e Department of Dermatology, CHU Nice, Nice, France
f Departement of Dermatology, CHU Caen, Caen, France
g Department of Dermatology, CHU Marseille, Marseille, France
h Unit of Pediatric Dermatology, CHU Reunion, Saint Pierre, France
i Department of Dermatology, CHU Nantes, Nantes, France
j Department of Dermatology, CHU Besançon, Besançon, France
k Department of Dermatology, CHU Brest, Brest, France
l Department of Dermatology, CHU Reims, Reims, France
m Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Universities of Nantes and Tours, Inserm 1246-SPHERE, CHU Tours, Tours, France
∗Correspondence to: Olivia Boccara, MD, Department of Dermatology, Hôpital Necker-Enfants Malades 149 rue de Sèvres 75015 Paris, FranceDepartment of DermatologyHôpital Necker-Enfants Malades149 rue de SèvresParis75015France
| Funding sources: None. |
|
| IRB approval status: The study was approved by the University of Paris, Paris-Centre IRB. |
|
| Key words: arteriovenous malformation; CM-AVM syndrome; EPHB4; magnetic resonance imaging; RASA1. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 4
P. 914-916 - octobre 2022 Retour au numéro
Article précédent
- Reporting of primary outcome measures and sample size calculations in randomized controlled trials in dermatology journals
- Alanna C. Bridgman, Meghan L. McPhie, Sophocles H. Voineskos, An-Wen Chan, Aaron M. Drucker
- Medicare Part D prescription trends in the use and cost of dermatology medications
- Angelina S. Hwang, Jordan R. Pollock, Matthew R. Buras, Aaron R. Mangold, David L. Swanson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?